Sexuality after breast cancer: cultural specificities of Tunisian population

Sexuality after breast cancer: cultural specificities of Tunisian population

Mnif Leila¹, Charfi Nada^1,&, Chaabene Kais², Masmoudi Jawaher¹

 

¹Psychiatry Department, Hedi Chaker Hospital, Sfax, Tunisia, ²Gynecology Department, Hedi Chaker Hospital, Faculty of Medicine of Sfax, Tunisia

 

 

^&Corresponding author
Nada Charfi, Psychiatry Department, Hedi Chaker Hospital, Sfax, Tunisia

 

 

 

 

It is widely recognized that women’s sexuality can be particularly complex after breast cancer, with sexual changes often becoming the most problematic aspect of a woman’s life. The impact of such changes can last for many years after successful treatment. Sexuality after breast cancer is considered like an important aspect of quality of life [1]. Factors related to treatment and its clinical implications may contribute to these problems. Women's intrapsychic experience of changes to sexuality includes a fear of loss of fertility, negative body image, feelings of sexual unattractiveness, loss of femininity, depression and anxiety, as well as alterations to a sense of sexual self [2]. A growing number of studies have been conducted that explore the sexual experiences in women presented breast cancer from diverse ethnocultural groups [3]. The meaning of breast cancer for women’s differs from a culture to another. The study aims to evaluate the changes in sexual life after treatment of breast cancer in Tunisian women and to identify the influence of demographic and clinical factors on sexuality.

 

 

Breast cancer patient’s post-primary treatment participated in the present study. Criteria for participating included: being in remission for at least 3 months, not receiving any oncologic therapy at the moment of the study and being able to communicate. Women with metastatic cancer were excluded. Those patients were previously referred to the Department of Gynecology in Sfax University Hospital for breast surgery during the period from 2010 to 2013, and then they had all received adjuvant therapy. They were identified at the hospital patient registration department. The phone number of each patient was obtained to contact her by telephone. The selected patients were invited to attend the hospital to collaborate to the study. The study's purpose was explained to each patient and consent was obtained orally. Only 50 eligible patients agreed to participate. Among the other contacted women, 15 were not found, 5 had passed away and 10 did not consent to the study. A sociodemographic form, composed by questions related to personal characteristics (age, socioeconomic level, hormonal status, sexual problems after cancer…) and their partners characteristics (sexual problems, marital relationship) was utilized for data collection. Clinical data (cancer staging, surgical therapy, adjuvant therapy) were collected from patients’ files. All the files and medical records were consulted after patient’s permission. Sexuality and body image was evaluated using the specific scale of breast cancer QLQ-BR23 [4], which is an additional module to the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 questionnaire [5]. An Arabic translation of this questionnaire is already approved by the authors of the instrument [6]. Screening for emotional disorders has been done using the HAD scale (Hospital anxiety and depression scale), which is a structured self-administered questionnaire of 14 items developed by Zigmond and Snaith in 1983 [7]. We also used a dialectal Arabic version of the questionnaire which is validated [8]. The data were analysed using the SPSS in its 11th version. Descriptive statistics were used to analyze demographic and clinical data. The mean QLQ-BR23 sexual functioning and satisfaction cores and sociodemographic and clinical variables were compared using ANOVA (General Linear Model). The correlations between sexual functioning and satisfaction and body image were calculated using Spearman’s Correlation Coefficient and a multiple regression model. The domain of body image (QLQ-C30) variable was the predictor variable. The t-student test was used to compare sexuality and body image according to emotional disorders. P < 0.05 was considered statistically significant.

 

 

Demographic characteristics of the study sample

 

The average age of patients studied was 52.06 years with extremes of 32 and 77 years (SD = 10.07 years). The grouping by age showed that 68% of patients were aged 40-60 years. The socioeconomic level was low in 44% of cases. The majority of our patients were married (94%).

 

Menopause

 

The majority of patients were postmenopausal women (90%) during the evaluation. Of the 25 not yet menopausal patients at diagnosis, 16 (64%) had presented a menopause induced by the effect of adjuvant therapy.

 

Clinical and therapeutic characteristics

 

Age of patient at diagnosis: the mean age at time of primary diagnosis was 49.66 years with extremes of 30 and 70 years (SD= 10.2 years). Most patients (86%) were over the age of 40 years at the time of primary diagnosis of breast cancer.

 

Duration of remission: the average duration of patients’ remission was 17.4 months with a standard deviation of .17 months with a minimum of 3 months and a maximum of 40 months (3 years and 4 months).

 

Breast surgery and adjuvant therapy: forty-one patients (82%) were treated with mastectomy type Patey. Breast conserving therapy with lumpectomy was performed in 9 patients (18%). All the patients received adjuvant chemoradiotherapy.

 

Endocrine therapy: endocrine therapy, represented by anti-estrogens, was shown in 32 patients (64%).

 

Hormonal status after cancer treatment: among the 25 patients not yet menopausal at diagnosis, 16 (64%) had presented menopause induced by the effect of adjuvant therapy.

 

Sexuality after breast cancer

 

Sexual problems after breast cancer: a decrease in the frequency of sexual intercourses after cancer was reported by 53.2% of patients (N = 25) sexually active. The diminished sense of sexual attractiveness was observed in 80.9% of patients and 42.5% of women had presented dyspareunia (Table 1).

 

Partner sexuality: women interviewed reported that eighteen partners (38.3%) have changed in their sexual function after the illness: decreased libido in 55.6% of cases (N = 10), sexual dissatisfaction in 27.8% of cases (N = 5) and finally erectile dysfunction in 16.7% of cases (N = 3).

 

Changes in the couple's relationship after cancer: among the subgroup of married women (N = 47), the marital relationship before illness was good for 43 patients (91.48%) and confrontational for 4 patients (8.52%). Thirty-two patients (68.08%) among 47 married describe a change in their marital relationship after cancer (Table 2).

 

Sexuality at the QLQ-BR23: the patients had poor sexual functioning and sexual satisfaction and the mean scores were respectively 45.3% and 43.9% (Table 3).

 

Predictors of sexual problems: additional analyses indicated that menopausal status and sexual difficulties in the partner was significantly related to poorer sexual satisfaction (p respectively 0.018 and 0.014) (Table 4).

 

Impact of body image on sexuality: the mean score of body image was 47.7% and its alteration had no significant impact on the themes of sexuality (Table 5).

 

Sexuality and emotional disorders

 

Anxiety and depression scale: HAD: according to a categorical approach referring to the HAD scale, 42% of patients in our study (N = 21) had anxiety and 44% (N = 22) had depression.

 

The impact of emotional state on sexuality: there was a statistically significant difference between anxious patients and those with normal mood for item sexual satisfaction. The perception of body image was more negative for anxiety and depression patients, compared with patients with normal mood (Table 6).

 

 

Thanks to early detection and treatment improvement, the mortality rate from Breast Cancer has declined over the past 20 years [9, 10]. Approximately 91% of women with breast cancer now survive for more than 5years [10]. Despite improved survival rates, the literature describes a wide range of difficulties in patients’ day-to-day life arising from breast cancer and associated treatment [2, 11]. Survivors face a multitude of challenges, including issues related to fertility and sexuality [12]. Changing the frequency of sex was a common disorder reported by our patients. Indeed, 53.2% of sexually active women had reported a decrease in the frequency of reporting sexual intercourse. The number of sexual intercourse had increased for a minority of women (8.5%). This variability reflects the impact of breast cancer on sexual activity which differs from one couple to another. For some, sexuality remains important but the recovery of sexual activity is difficult anyway. For others, cancer allows some women and even some couples, to "use" the cancerous disease and its treatments to end a heavy sexuality, experienced as a constraint [13]. Fahami F reported that 47% of Iranian women who presented in the majority of cases, a breast cancer, had sexual dysfunction [14]. There was a significant correlation between sexual functioning and age, occupation, educational level, and treatment duration. There was also a significant correlation between the stage of disease, primary disorder (0.003), and recent disorder (0.028). According to various studies, oriental women reported more sexual dysfunctions compared to women in Western countries [15, 16].

 

Sexual dysfunctions are common to gynecologic cancer treatment, where most women experienced impaired sexual function [17]. Zeng YC study revealed that sexual dysfunction was an important concern among Chinese women with gynecologic cancer (62.2%) [18] .The rate of sexual inactivity (70.5%) was relatively high. Reasons for sexual inactivity were related to worry about possibly weakening the potency of treatment (46.5%), fear of cancer recurrence (41.1%), and lack of sexual interest (31%) [18]. In assessing the quality of sexual life, we have found poor average scores on functional scales QLQ-BR23 regardless of age. Speer and al [19] had found that breast cancer sexual functioning was significantly poorer than normal controls in all areas but desire. Breast cancer confronts the woman to complex personal and marital disorders related to the sexual sphere. It is likely to affect three main areas of sexuality: sexual identity, sexual function and sexual relationship [20]. The diminished sense of sexual attractiveness was also found in the majority of our patients (76%). Negative perceptions of body image among breast cancer survivors include dissatisfaction with appearance, perceived loss of femininity and body integrity, reluctance to look at one’s self naked, feeling less sexually attractive, self-consciousness about appearance, and dissatisfaction with surgical scars [21]. This result can be explained by the sensitivity of the affected organ and the physical and psychological impact of illness and treatment received on body image. But, all married women were sexually active, in this study. This may be, reflect the concept of “sexual obedience” in our culture which is based on the social duty of women to meet the husbund’s sexuel needs.

 

Our study showed a statistically significant correlation between alteration of sexual satisfaction and perception of body image with the presence of anxiety and depression. In the literature, breast cancer diagnosis and treatment is reported to lead patients to psychological problems such as anxiety, depression, anger, uncertainty about the future, hopelessness, helplessness, fear of relapse, decreased self-esteem, body image distortion, fear of losing the feminine characteristics and fear of death [22]. The meta-synthesis performed by Berterö [23], revealed 4 aspects of the self-affected by the diagnosis of breast cancer and its treatment: awareness of their own mortality, living with an uncertain certainty, attachment validation, and redefinition of self. In addition, anxious and / or depressed women had more altered body image. This maintains the relationship between the negative body image, deterioration of sexual life, anxiety and depression [21, 24]. However, in our study the functioning and sexual satisfaction of patients were independent of altered body image. Sexual self-schema appears to be an important concept in predicting sexual dysfunction in others study [25], but, the relationship of good body image with the resumption of sexual relations and sexual dysfunction is inconsistent. While the majority of studies have found this relationship, a few have not [21]. Indeed, it is suggested that the body image and sexuality are more affected by breast cancer during the first year of survival [21, 26]. The good marital relationship could explain our results since a negative evolution of the marital relationship after cancer had affected only 21.8% of cases. Bertero study's [23] highlights the existential process that women of many cultures move through as they incorporate the meaning of breast cancer into their lives. Spirituality was reported to be the main coping mechanism used during all phases of the cancer experience [27]. In fact, spirituality may improve acceptance of body alterations. Body image was the less altered dimension, in QLQ-BR23 functional scales in our study since believer’s subjects represent the majority of our society.

 

The emergence of sexual dysfunction type dyspareunia (61.5%) and vaginal dryness (61.3%) could justify the decrease in the frequency of intercourses in the group of our patients. Speer and al. [19] had observed that women who were older had significantly more concerns about vaginal lubrication and pain. This type of problem is particularly common after adjuvant chemotherapy. It is considered in the literature as the most responsible for the problems of lubrication and dyspareunia [28]. A review of the literature suggests that breast cancer patients who undergo chemotherapy are at high risk for sexual dysfunction after treatment [29]. Chemotherapy has been shown to be associated with short and long-term effects on sexual functioning and quality of life in breast cancer, and it is anticipated that this would extend to gynecologic cancers also [25]. Common effects of chemotherapy on ovarian function include temporary or permanent amenorrhea due to premature ovarian failure. Rates of amenorrhea can reach 80% in women under 40 years of age with poor prognosis tumors who are prescribed more aggressive regimens [30]. The addition of endocrine treatments to chemotherapy in breast cancer does not appear to affect levels of sexual functioning, although this may depend on the age of the woman [25]. In our patients, there was no relation between type of surgery and sexual functioning or satisfaction. But Sun and al. [31] had reported that patients in the reconstruction after total mastectomy group had significantly better outcomes on the sexual scale of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire breast cancer-specific module and arm symptoms than the total mastectomy group.

 

In contrast, Thors [29] had found in his study that there is little evidence of a link between type of surgical treatment (eg, lumpectomy versus mastectomy) or treatment with tamoxifen and sexual functioning outcomes. Binney observed in North Carolina that there was no statistically significant relationship between the sexual functioning of women with breast cancer and the type of treatment (chemotherapy, radiotherapy, and surgery) [32]. The study results of Sbitti and al [33] on 125 women with breast cancer in Morocco indicated that there was no statistical relationship between sexual dysfunction and age, level of education, disease stage, and type of treatment. Fahmi study results showed no significant relationship between cancer type and type of sexual disorder: primary (0.403) or recent (0.416) [14]. In our study, all the patients had received chemotherapy, and sexuality was independent of surgical or endocrine treatment. Additional analyses indicated that menopausal status and sexual difficulties in the partner were significantly related to poorer sexual satisfaction (p respectively 0.018 and 0.014). These two factors were probably for women the warning signs of the end of their sexuality, in a society where divorce is poorly accepted and menopause is designed by “despair age”. Several studies [34, 35] reported the installation of sexual difficulties in the majority of partners of women with cancer. Both patient and partner are dealing with concerns about survival [36]. The breast cancer level of relationship distress was the most significant variable affecting arousal, orgasm, lubrication, satisfaction, and sexual pain [19]. Depression and having traditional role preferences are the most important determinants of lower sexual desire [19]. Finally, the quality of a woman's partnered relationship consistently predicts sexual health post-breast cancer -specific- reinforcing the importance of recognizing the intersubjective nature of issues surrounding breast cancer and sexuality [37]. It is therefore essential to involve the spouse in the care of the patient and encourage couples to improve communication. Information provision can also prevent or ameliorate distress [38]. Communication with women about sexual issues is vital, but evidence suggests that is lacking [25]. Ussher JM reported that substantial proportion of patients (68%) search for information on physical changes, sexual response, relationship issues, psychological consequences, and body image or identity [38]. These findings provide clinicians and cancer organizations with specific suggestions about sexual information needs after breast cancer and the modalities which are preferred, to prevent and ameliorate distress [38]. Martin described how exercise facilitated counseling in survivors of breast and prostate cancer, by creating mutual aid and trust, and counseling helped participants with self-identity, sexuality, and returning to normalcy [39].

 

 

Considering the specific impact on sexuality and partner relationship of non-metastatic breast cancer and its treatments, it seems fundamental to educate physicians and caregivers to this dimension, and facilitate dialogue on this topic. The physical determiner does not seem to resound negatively on women's sexuality while the psychological side most likely intervenes in sexual satisfaction. Hence the importance of psycho - oncological care that will accompany the patient and her spouse to help them anticipate the changes related to the disease and its treatments.

 

 

The authors declare no competing interest.

 

 

All the authors have read and approved with the final version of the manuscript.

 

 

The authors thank Professor Mohamed Guermazi and all the gynecology team for study coordination and management; Mrs Fedia Boughacha for statistical and database assistance and all the participating providers for their assistance with recruitment.

 

 

Table 1: frequency of sexual problems in the two samples

Table 2: marital relationship changes after cancer

Table 3: mean scores of functional scales at QLQ-BR23

Table 4: predictive factors of sexual problems

Table 5: correlations between body image and sexuality

Table 6: correlations between emotional disorders and sexuality

 

 

1. Ganz PA, Desmond K, Belin TR, Meyerowitz BE, Rowland JH. Predictors of sexual health in women after a breast cancer diagnosis. J Clin Oncol. 1999;17(8):2371-80. PubMed | Google Scholar


2. Gilbert E, Ussher JM, Perz J. Sexuality after breast cancer: a review.Maturitas. 2010;66:397-407. PubMed | Google Scholar


3. Howard AF, Balneaves LG, Bottorff JL.Ethnocultural women's experiences of breast cancer: a qualitative meta-study. Cancer Nurs.2007 Jul-Aug;30(4):E27-35. PubMed | Google Scholar


4. Sprangers MA, Groenvold MA, Arraras JI, Franklin J, te Velde A, Muller M and al. The European Organization for Research and Treatment of Cancer breast cancer-specific quality of-life questionnaire module: first results from a three-country field study. J Clin Oncol.1996 Oct; 14(10):2756-68. PubMed | Google Scholar


5. Aaronson NK. The European Organization for Research of Treatment of Cancer-specific quality of life questionnaire module: first results from a three country field. J Clin Oncol. 1993; 85:365-76. PubMed | Google Scholar


6. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst.1993 Mar 3;85(5):365-7. PubMed | Google Scholar


7. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70.(8). PubMed | Google Scholar


8. Malasi TH, Mirza IA, El-Islam MF. Validation of the Hospital Anxiety and Depression Scale in Arab patients. Acta Psychiatr Scand . 1991;84:323-6. PubMed | Google Scholar


9. Guérin S, Hill C. [Cancer epidemiology in France in 2010, comparison with the USA]. Bull Cancer (Paris). 2010;97:47-54. PubMed | Google Scholar


10. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA. SEER Cancer Statistics Review, 1975-2010, National Cancer Institute. Bethesda, MD, Based on November 2012 SEER Data Submission, Posted to the SEER Web Site, April 2013. Google Scholar


11. Roche N. Follow-up after treatment for breast cancer in young women.Breast.2006;15(Suppl 2):S71-5. PubMed | Google Scholar


12. Ben Charif A, Bouhnik AD, Rey D, Provansal M, Courbiere B, Spire B, Mancini J. Satisfaction with fertility- and sexuality-related information in young women with breast cancer—ELIPPSE40 cohort. BMC Cancer. 2015 Aug 5;15:572. PubMed | Google Scholar


13. Santos DB, Vieira EM. Scripts de la sexualité dans le contexte du cancer du sein. Sexologies. (2014), http://dx.doi.org/10.1016/j.sexol.2010.002. Google Scholar


14. Fahami F, Mohamadirizi S. Relationship of sexual dysfunction and its associated factors in women with genital and breast cancers. Iran J Nurs Midwifery Res. 2015 Jul-Aug; 20(4): 516-520. PubMed | Google Scholar


15. Laumann EO, Nicolosi A, Glasser DB, Paik A, Gingell C, Moreira E et al. Sexual problems among women and men aged 40-80 y: Prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors.Int J Impot Res.2004;17:39-57. PubMed | Google Scholar


16. Moreira E, Brock G, Glasser D, Nicolosi A, Laumann E, Paik A et al. Help-seeking behavior for sexual problems: The Global Study of Sexual Attitudes and Behaviors. Int J Clin Pract.2005;59:6-. PubMed | Google Scholar


17. Lara LA, de Andrade JM, Consolo FD,Romao AP. Women's poorer satisfaction with their sex lives following gynecologic cancer treatment. Clin J Oncol Nurs.2012 Jun 1;16(3):273-7. PubMed | Google Scholar


18. Zeng YC, Li Q, Li X, Loke AY. Chinese women's sexuality concerns after gynecologic cancer. Cancer Nurs. 2012 Jul-Aug;35(4):257-64. PubMed | Google Scholar


19. Speer JJ, Hillenberg B, Sugrue DP, Blacker C, Kresge CL, Decker VB, Zakalik D, Decker DA. Study of sexual functioning determinants in breast cancer survivors. Breast J.2005 Nov-Dec;11(6):440-7. PubMed | Google Scholar


20. Graziottin A, Rovei V. Sexuality after breast cancer. Sexologies.2007;16:292-8. PubMed | Google Scholar


21. Fobair P, Stewart SL, Chang S, D’Onofrio C, Banks PJ, Bloom JR. Body image and sexual problems in young women with breast cancer. Psycho Oncol. 2006;15(7):579-94. PubMed | Google Scholar


22. Nazlican E, Akbaba M, Okyay RA. Evaluation of Depression in Newly Diagnosed Breast Cancer Cases in Hatay Povince of Turkey in 2011. Asian Pacific journal of cancer prevention: APJCP. 06/2012; 13(6):2557-61. PubMed | Google Scholar


23. Bertero C, Chamberlain Wilmoth M. Breast cancer diagnosis and its treatment affecting the self: a meta-synthesis. Cancer Nurs.2007 May-Jun;30(3):194-202; quiz 203-4. PubMed | Google Scholar


24. Perdrizet-Chevallier C, Reich M, Lesur A. Dépression et anxiété chez les femmes souffrant de cancers gynécologiques. Ann Med Psychol. 2008;166:292-96. PubMed | Google Scholar


25. Stead ML. Sexual dysfunction after treatment for gynaecologic and breast malignancies. Curr Opin Obstet Gynecol.2003 Feb;15(1):57-61. PubMed | Google Scholar


26. Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE. Life after breast cancer: understanding women’s health-related quality of life and sexual functioning. J Clin Oncol. 1998;16(2):501-14. PubMed | Google Scholar


27. Tate JD.The role of spirituality in the breast cancer experiences of African American women.Cancer Nurs.2007 May-Jun;30(3):194-202. PubMed | Google Scholar


28. Alder J, Zanetti R, Wight E, Urech C, Fink N, Bitzer J. Sexual dysfunction after premenopausal stage I and II breast cancer: do androgens play a role? J Sex Med. 2008;5:1898-906. Google Scholar


29. Thors CL, Broeckel JA, Jacobson PB. Sexual functioning in breast cancer survivors.Cancer Control.2001 Sep-Oct;8(5):442-8. PubMed | Google Scholar


30. This P. Breast cancer and fertility: critical review, considerations and perspectives. Bull Cancer.2008;95:17-25. PubMed | Google Scholar


31. Sun Y, Kim SW, Heo CY, Kim D, Hwang Y, Yom CK, Kang E. Comparison of quality of life based on surgical technique in patients with breast cancer. Jpn J Clin Oncol.2014 Jan;44(1):22-7. PubMed | Google Scholar


32. Binney GL. Sexual Satisfaction Among Young. Breast Cancer Survivors.2011. Google Scholar


33. Sbitti Y, Kadiri H, Essaidi I, Fadoukhair Z, Kharmoun S, Slimani K. Breast cancer treatment and sexual dysfunction: Moroccan women's perception. BMC Womens Health. 2011;11:2-5. PubMed | Google Scholar


34. Razavi D, Delvaux N. Le cancer, le malade et sa famille. Paris: Masson. 2002. Google Scholar


35. Weisman AD, William Worden J. The emotional impact of recurrent cancer. J Psychosocial Oncol. 1986;3(4):5-16. PubMed | Google Scholar


36. Burbie GE, Polinsky ML. Intimacy and sexuality after cancer treatment: restoring a sense of wholeness. J Psychosoc Oncol. 1992;10:19-33. PubMed | Google Scholar


37. Gilbert E, Ussher JM, Perz J. Sexuality after gynaecological cancer: a review of the material, intrapsychic, and discursive aspects of treatment on women's sexual-wellbeing. Maturita.2011 Sep;70(1):42-57. PubMed | Google Scholar


38. Ussher JM, Perz J, Gilbert E. Information needs associated with changes to sexual well-being after breast cancer. J Adv Nurs. 2013 Feb; 69(2):327-37. PubMed | Google Scholar


39. Martin E, Bulsara C, Battaglini C, Hands B, Naumann FL. Breast and Prostate Cancer Survivor Responses to Group Exercise and Supportive Group Psychotherapy. J Psychosoc Oncol.2015 Aug 28:0. PubMed | Google Scholar